JPS55118918A - Production of quinazolone ring-containing epoxy resin - Google Patents

Production of quinazolone ring-containing epoxy resin

Info

Publication number
JPS55118918A
JPS55118918A JP2636779A JP2636779A JPS55118918A JP S55118918 A JPS55118918 A JP S55118918A JP 2636779 A JP2636779 A JP 2636779A JP 2636779 A JP2636779 A JP 2636779A JP S55118918 A JPS55118918 A JP S55118918A
Authority
JP
Japan
Prior art keywords
compound
quinazolone
epoxy
production
dicarboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2636779A
Other languages
Japanese (ja)
Inventor
Akira Fukami
Shohei Eto
Shigeru Kubota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Electric Corp
Original Assignee
Mitsubishi Electric Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Electric Corp filed Critical Mitsubishi Electric Corp
Priority to JP2636779A priority Critical patent/JPS55118918A/en
Publication of JPS55118918A publication Critical patent/JPS55118918A/en
Pending legal-status Critical Current

Links

Landscapes

  • Epoxy Resins (AREA)

Abstract

PURPOSE: To obtain the title epoxy compound useful for cast and laminating having improved heat resistance and compatibility with a curing agent, by reacting a specific quinazolone ring-containing dicarboxylic acid compound with an epoxy compound.
CONSTITUTION: A) A dicarboxylic acid compound shown by the formula (R1 is a liphatic or aromatic bifunctional group; R2 is organic bifunctional group) having two quinazolone rings in its molecule is reacted with B) an epoxy compound having two or more (preferably 2W20) epoxy groups to give the desired compound. The compound A is obtained by heating a bisoxazinon compound and an aminocarboxylic acid compound together with an organic polar solvent. An epoxidized diolefin or diene may be preferably cited as the compound B. The reaction between A and B is carried out preferably at 180W200°C for 0.5W3 hours under heating.
COPYRIGHT: (C)1980,JPO&Japio
JP2636779A 1979-03-06 1979-03-06 Production of quinazolone ring-containing epoxy resin Pending JPS55118918A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2636779A JPS55118918A (en) 1979-03-06 1979-03-06 Production of quinazolone ring-containing epoxy resin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2636779A JPS55118918A (en) 1979-03-06 1979-03-06 Production of quinazolone ring-containing epoxy resin

Publications (1)

Publication Number Publication Date
JPS55118918A true JPS55118918A (en) 1980-09-12

Family

ID=12191521

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2636779A Pending JPS55118918A (en) 1979-03-06 1979-03-06 Production of quinazolone ring-containing epoxy resin

Country Status (1)

Country Link
JP (1) JPS55118918A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035075A1 (en) * 2001-10-19 2003-05-01 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
US7932260B2 (en) 2004-05-13 2011-04-26 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US8440677B2 (en) 2009-03-24 2013-05-14 Gilead Calistoga Llc Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
US8546409B2 (en) 2009-04-20 2013-10-01 Gilead Calistoga Llc Methods of treatment for solid tumors
US8691829B2 (en) 2009-07-21 2014-04-08 Gilead Calistoga Llc Treatment of liver disorders with PI3K inhibitors
US8865730B2 (en) 2012-03-05 2014-10-21 Gilead Calistoga Llc Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
AU2001255667C1 (en) * 2000-04-25 2016-06-09 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
US9708327B2 (en) 2013-12-20 2017-07-18 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US10047060B2 (en) 2013-12-20 2018-08-14 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
US10154998B2 (en) 2008-11-13 2018-12-18 Gilead Calistoga Llc Therapies for hematologic malignancies
US11021467B2 (en) 2014-06-13 2021-06-01 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492389B2 (en) 2000-04-25 2013-07-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US10010550B2 (en) 2000-04-25 2018-07-03 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US8623881B2 (en) 2000-04-25 2014-01-07 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US6949535B2 (en) 2000-04-25 2005-09-27 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
US10695349B2 (en) 2000-04-25 2020-06-30 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US8138195B2 (en) 2000-04-25 2012-03-20 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US10398695B2 (en) 2000-04-25 2019-09-03 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US8653077B2 (en) 2000-04-25 2014-02-18 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US8637533B2 (en) 2000-04-25 2014-01-28 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US9487772B2 (en) 2000-04-25 2016-11-08 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
AU2001255667C1 (en) * 2000-04-25 2016-06-09 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
WO2003035075A1 (en) * 2001-10-19 2003-05-01 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
JP4945060B2 (en) * 2001-10-19 2012-06-06 イコス・コーポレイション Inhibition of human phosphatidylinositol 3-kinase delta
JP2005509635A (en) * 2001-10-19 2005-04-14 アイコス コーポレイション Inhibition of human phosphatidylinositol 3-kinase delta
US8779131B2 (en) 2004-05-13 2014-07-15 Icos Corporation 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
US8586597B2 (en) 2004-05-13 2013-11-19 Icos Corporation 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
US7932260B2 (en) 2004-05-13 2011-04-26 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US9149477B2 (en) 2004-05-13 2015-10-06 Icos Corporation 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
USRE44599E1 (en) 2004-05-13 2013-11-12 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US8207153B2 (en) 2004-05-13 2012-06-26 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US10906907B2 (en) 2004-05-13 2021-02-02 Icos Corporation Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof
USRE44638E1 (en) 2004-05-13 2013-12-10 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US10336756B2 (en) 2004-05-13 2019-07-02 Icos Corporation (S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta
US10154998B2 (en) 2008-11-13 2018-12-18 Gilead Calistoga Llc Therapies for hematologic malignancies
US8440677B2 (en) 2009-03-24 2013-05-14 Gilead Calistoga Llc Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
US8546409B2 (en) 2009-04-20 2013-10-01 Gilead Calistoga Llc Methods of treatment for solid tumors
US8691829B2 (en) 2009-07-21 2014-04-08 Gilead Calistoga Llc Treatment of liver disorders with PI3K inhibitors
US8865730B2 (en) 2012-03-05 2014-10-21 Gilead Calistoga Llc Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US10730879B2 (en) 2012-03-05 2020-08-04 Gilead Calistoga Llc Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US9469643B2 (en) 2012-03-05 2016-10-18 Gilead Calistoga, LLC. Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US10047060B2 (en) 2013-12-20 2018-08-14 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
US10442805B2 (en) 2013-12-20 2019-10-15 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US10414737B2 (en) 2013-12-20 2019-09-17 Gilead Sciences, Inc. Process methods for phosphatidylinositol 3-kinase inhibitors
US10059677B2 (en) 2013-12-20 2018-08-28 Gilead Calistoga Llc Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof
US9708327B2 (en) 2013-12-20 2017-07-18 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US10954199B2 (en) 2013-12-20 2021-03-23 Gilead Sciences, Inc. Process methods for phosphatidylinositol 3-kinase inhibitors
US11021467B2 (en) 2014-06-13 2021-06-01 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors

Similar Documents

Publication Publication Date Title
JPS55118918A (en) Production of quinazolone ring-containing epoxy resin
JPS5749621A (en) Preparation of heat-resistant resin
JPS55118917A (en) Production of quinazolone ring-containing epoxy resin
JPS562322A (en) Preparation of polyamide resin
JPS57131227A (en) Photopolymer and its production
JPS5511530A (en) Preparation of amine compound
JPS56141310A (en) Curable resin composition
JPS54142298A (en) Heat-resistant curable resin composition
JPS56112933A (en) Thermoplastic polyamide-imide copolymer and production thereof
JPS57159764A (en) Preparation of bismaleimide compound
JPS6426555A (en) Addition reaction type ether imide compound, production and composition thereof
JPS5794019A (en) Production of oxazoline ring-terminated polyester- polyamide
JPS562323A (en) Preparation of polyamide resin
JPS5734128A (en) Production of imide type prepolymer
JPS5780424A (en) Thermosetting composition forming heat-resistant cured resin product
JPS6433118A (en) Epoxy resin composition and its cured product
JPS5662821A (en) Production of condensate
JPS55115423A (en) Manufacture of adamantane-epoxy resin
JPS5728129A (en) Curing agent for epoxy resin
JPS56115783A (en) Preparation of diisobutenylsuccinic anhydride
JPS5516052A (en) Preparation of polyimide
JPS5645948A (en) Production of composite material
JPS54159494A (en) Resin composition
JPS5698228A (en) Curing agent for epoxy resin
JPS5671068A (en) 3,3'-dinitro-4,4'-diimidodiphenyl sulfone and its preparation